Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021

ACCESS Newswire
20 Jan 2021, 18:13 GMT+10

DURHAM, NC / ACCESSWIRE / January 20, 2021 / Heat Biologics, Inc. ('Heat') (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference.

The Heat's presentation will be webcast live at 11:30 a.m. EST on Thursday, January 21, 2021. The presentation will be open to registered conference attendees, institutional investors and investor relations professionals, who may register to view the live webcast at https://b-riley-oncology-investor-conference.events.issuerdirect.com/signup. After completion of the event, a replay of the presentation will be publicly available under the 'Investors - News/Events' tab on the Heat Biologics website at www.heatbio.com.

About Heat Biologics, Inc.

Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The Company's gp96 platform is designed to activate immune responses against cancer or pathogenic antigens. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, HS-130 in Phase 1, and a COVID-19 vaccine program in preclinical development. In addition, Heat is also developing a pipeline of proprietary immunomodulatory antibodies, including PTX-35 which is enrolling in a Phase 1 trial.

Media and Investor Relations Contact

David Waldman
+1 919 289 4017
[email protected]

SOURCE: Heat Biologics, Inc.

View source version on accesswire.com:
https://www.accesswire.com/624982/Heat-Biologics-CEO-to-Participate-in-a-Fireside-Chat-at-the-B-Riley-Securities-Oncology-Investor-Conference-on-Jan-21-2021

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Illinois Intelligencer.

More Information

null in null

North America

Section

"Can't afford to dwell on it": Tharoor on criticisms heaped on him by Congress

Brasilia [Brazil], June 1 (ANI): All-party delegation leader and Congress MP Shashi Tharoor on Sunday underscored the importance of...

Trump withdraws nomination of Issacman to lead NASA, days after Musk departs from White House

Washington DC [US], June 1 (ANI): President Donald Trump has withdrawn the NASA nomination of Jared Isaacman, a billionaire tech entrepreneur...

Justin Allgaier wins at Nashville for second time

(Photo credit: Randy Sartin-Imagn Images) LEBANON, Tenn. -- Justin Allgaier joked before the start of Saturday's Tennessee Lottery...

Taiwan detects Chinese incursions around region

Taipei [Taiwan], June 1 (ANI): Taiwan's Ministry of National Defence detected five Chinese aircraft, seven Chinese vessels and one...

Defence, trade and technology discussed during Foreign Secretary Vikram Misri's visit to US

New Delhi [India], June 1 (ANI): Foreign Secretary Vikram Misri visited Washington DC from May 27 to 29, where he held a series of...

"We gave a befitting reply": All-party delegation member Anand Sharma in Ethiopia

Addis Ababa [Ethiopia], June 1 (ANI): Congress MP Anand Sharma, who is part of the multi-party delegation to Ethiopia on Saturday (local...

International

Section